ISRG vs XOM: Which Is the Better Buy?
Side-by-side comparison of Intuitive Surgical, Inc. and Exxon Mobil Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-01.
Intuitive Surgical, Inc. · Healthcare
$451.29
+45.0% upside to fair value
Grade B
High Quality
VS
Exxon Mobil Corporation · Energy
$154.46
-40.5% upside to fair value
Grade C
QuantHub Verdict
ISRG has more upside to fair value
(+45.0%).
XOM trades at a lower forward P/E
(23.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ISRG |
XOM |
| Current Price |
$451.29 |
$154.46 |
| Fair Value Estimate |
$654.37 |
$91.87 |
| Upside to Fair Value |
+45.0%
|
-40.5%
|
| Market Cap |
$160.3B |
$642.0B |
| Forward P/E |
53.8x
|
23.2x
|
| EV / EBITDA |
40.5x
|
10.3x
|
| Price / Sales |
15.2x
|
2.0x
|
| Price / FCF |
64.3x
|
27.2x
|
| Revenue Growth YoY |
+23.0%
|
-1.3%
|
| Gross Margin |
66.3%
|
21.7%
|
| Operating Margin |
30.5%
|
10.5%
|
| Return on Equity |
17.0%
|
11.0%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.55%
|
3.68%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Intuitive Surgical, Inc. is a leading healthcare company specializing in robotic-assisted surgery through its flagship da Vinci system, which has established a durable competitive moat with approximately 10,000 systems installed globally and nearly 17 million procedures performed by the end of 2024. The company benefits from a high-quality business model characterized by 85% recurring revenue, st…
Exxon Mobil Corporation operates as a global integrated oil and gas company with significant operations in upstream, energy products, chemical products, and specialty products segments. The company benefits from a highly experienced management team with decades of internal tenure, led by CEO Darren Woods. Despite strong cash flow generation and operational scale, Exxon is currently overvalued, tr…
Accumulation Zones
| Metric |
ISRG |
XOM |
| Zone Low |
$490.78 |
$68.90 |
| Zone High |
$556.21 |
$78.09 |
| In Buy Zone? |
Yes
|
No
|